01—Abstract
Summary
Summary of the 8-K filed May 22, 2025. Cited figures are marked; the original filing is the authoritative source.
On May 22, 2025, MicroStrategy Incorporated d/b/a Strategy (the "Company") entered into a Sales Agreement with TD Securities (USA) LLC, Barclays Capital Inc., and The Benchmark Company, LLC, as sales agents, under which the Company may issue and sell shares of its 10.00% Series A Perpetual Strife Preferred Stock, $0.001a par value, having an aggregate offering price of up to $2.1 billion.
The shares may be sold from time to time through an at-the-market offering or other permitted methods, including negotiated transactions or block trades, in amounts and at times determined by the Company. Neither the Company nor the Agents are obligated to sell any shares, and no assurance is given that any sales will occur. The Company agreed to pay the Agents commissions of up to 2.0%b of aggregate gross proceeds from each sale, along with customary indemnification and contribution rights.
Sales are made under a prospectus supplement filed May 22, 2025, under an automatic shelf registration statement that became effective January 27, 2025 (File No. 333-284510). The accompanying press release states that sales will be made in a disciplined manner over an extended period, taking into account the trading price and volume of the preferred stock, and that net proceeds are intended for general corporate purposes, including the acquisition of bitcoin, and for working capital.
02—Key points
Key Highlights
- Strategy entered a Sales Agreement enabling sales of up to $2.1 billion of its 10.00% Series A Perpetual Strife Preferred Stock through TD Securities (USA) LLC, Barclays Capital Inc., and The Benchmark Company, LLC.
- Sales may be made via at-the-market offerings or other permitted methods, including negotiated transactions or block trades, at the Company's discretion over time.
- The Agents receive commissions of up to 2.0% of gross proceeds from each sale of shares.
- Offerings are made under a prospectus supplement filed May 22, 2025, under an automatic shelf registration statement effective January 27, 2025 (File No. 333-284510).
- The Company states net proceeds are intended for general corporate purposes, including the acquisition of bitcoin, and for working capital.
- The filing states no obligation exists for the Company or Agents to sell any shares, and no assurance is given regarding the amount, price, or timing of any sales.
- Wilmer Cutler Pickering Hale and Dorr LLP issued a legal opinion regarding the shares, filed as Exhibit 5.1.
03—Questions
Frequently Asked Questions
What securities are being offered under this Sales Agreement?
The Company may issue and sell shares of its 10.00% Series A Perpetual Strife Preferred Stock, $0.001 par value per share, with an aggregate offering price of up to $2.1 billion.
Who are the sales agents and how much do they earn?
The sales agents are TD Securities (USA) LLC, Barclays Capital Inc., and The Benchmark Company, LLC. The Company has agreed to pay them commissions of up to 2.0% of the aggregate gross proceeds from each sale, and to provide customary indemnification and contribution rights.
Is the Company required to sell the full $2.1 billion of shares?
No. Neither the Company nor the Agents have an obligation to sell any of the shares, and the filing states no assurance can be given that any shares will be sold or as to the price, amount, or timing of sales.
How will the Company use the proceeds?
According to the accompanying press release, net proceeds are intended for general corporate purposes, including the acquisition of bitcoin, and for working capital.
How are the shares registered for sale?
The shares are registered under an automatic shelf registration statement (File No. 333-284510) that became effective January 27, 2025, and offerings are made only by means of a prospectus supplement filed on May 22, 2025.
04—Continue